Literature DB >> 29741135

Polyreactive antibodies in CLL correlate with the level of immunoglobulins not the number of B lymphocytes.

Sreenivasulu Gunti1, Sarah E M Herman2, Raju V S R K Gottumukkala1, Ying Xiong1, Clare Sun2, Gilberto N Carmona1, Adrian Wiestner2, Abner L Notkins1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29741135      PMCID： PMC6226347          DOI： 10.1080/10428194.2018.1464159

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

Review 1.  Polyreactivity of antibody molecules.

Authors:  Abner Louis Notkins
Journal:  Trends Immunol       Date:  2004-04       Impact factor: 16.687

2.  Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells.

Authors:  Sooryanarayana Varambally; Yaron Bar-Dayan; Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Michael Horn; Marc Sorel; Yosefa Bar-Dayan; Giovina Ruberti; Michel D Kazatchkine; Srini V Kaveri
Journal:  Int Immunol       Date:  2004-03       Impact factor: 4.823

3.  The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies.

Authors:  Zhao-Hua Zhou; Yahong Zhang; Ya-Fang Hu; Larry M Wahl; John O Cisar; Abner Louis Notkins
Journal:  Cell Host Microbe       Date:  2007-03-15       Impact factor: 21.023

4.  Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire.

Authors:  Z J Chen; C J Wheeler; W Shi; A J Wu; C H Yarboro; M Gallagher; A L Notkins
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

Review 5.  Polyreactive Antibodies: Function and Quantification.

Authors:  Sreenivasulu Gunti; Abner Louis Notkins
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

6.  Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Clare Sun; Xin Tian; Yuh Shan Lee; Sreenivasulu Gunti; Andrew Lipsky; Sarah E M Herman; Dalia Salem; Maryalice Stetler-Stevenson; Constance Yuan; Lela Kardava; Susan Moir; Irina Maric; Janet Valdez; Susan Soto; Gerald E Marti; Mohammed Z Farooqui; Abner L Notkins; Adrian Wiestner; Georg Aue
Journal:  Blood       Date:  2015-09-03       Impact factor: 22.113

Review 7.  Humoral immunodeficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape.

Authors:  Almudena Sampalo; José A Brieva
Journal:  Leuk Lymphoma       Date:  2002-04

8.  Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV.

Authors:  Zhao-hua Zhou; Teresa Wild; Ying Xiong; Laine H Sylvers; Yahong Zhang; Luxia Zhang; Larry Wahl; Sharon M Wahl; Steven Kozlowski; Abner L Notkins
Journal:  Sci Rep       Date:  2013       Impact factor: 4.996

9.  IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.

Authors:  Kwan-Ki Hwang; Ashley M Trama; Daniel M Kozink; Xi Chen; Kevin Wiehe; Abby J Cooper; Shi-Mao Xia; Minyue Wang; Dawn J Marshall; John Whitesides; Munir Alam; Georgia D Tomaras; Steven L Allen; Kanti R Rai; Jane McKeating; Rosa Catera; Xiao-Jie Yan; Charles C Chu; Garnett Kelsoe; Hua-Xin Liao; Nicholas Chiorazzi; Barton F Haynes
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

10.  Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation.

Authors:  Sreenivasulu Gunti; Ronald J Messer; Chengfu Xu; Ming Yan; William G Coleman; Karin E Peterson; Kim J Hasenkrug; Abner L Notkins
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.